Cardiol Therapeutics Inc. (CRDL) vs Precision BioSciences, Inc. (DTIL)
A side-by-side comparison of Cardiol Therapeutics Inc. and Precision BioSciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CRDL
Cardiol Therapeutics Inc.
$1.34HealthcareDelayed quote: Oct 6, 2026, 11:49 AM EDT
DTIL
Precision BioSciences, Inc.
$6.35HealthcareDelayed quote: Oct 6, 2026, 11:45 AM EDT
Total return — CRDL vs DTIL
growth of $100 · dividends reinvested · last 8yCRDL -69.4% (-13.8%/yr)DTIL -98.8% (-42.4%/yr)CRDL compounded faster over this window
Log scale — wide-divergence pair
CRDL DTIL
CRDL vs DTIL: by the numbers
- •DTIL is the larger company ($175M vs $154M market cap).
- •Both run net losses; CRDL's is the smaller (0.00% vs -117.04% net margin).
Metrics side by side
Valuation
| Metric | CRDL | DTIL |
|---|---|---|
| P/S ratio | N/A | 3.89 |
| P/B ratio | 9.09 | 3.87 |
Profitability
| Metric | CRDL | DTIL |
|---|---|---|
| Gross margin | 0.00% | 100.00% |
| Operating margin | 0.00% | -152.19% |
| Net margin | 0.00% | -117.04% |
| ROE | -155.34% | -116.42% |
| ROIC | -165.56% | -30.23% |
Growth (annualized)
| Metric | CRDL | DTIL |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 7.13% |
| Total return CAGR (5Y) | -18.36% | -54.84% |
Frequently asked
- How have CRDL and DTIL total returns compared?
- Over the past 5 years, CRDL delivered -18.36% and DTIL delivered -54.84% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.